KARTHIK VADAMALAI to Rituximab
This is a "connection" page, showing publications KARTHIK VADAMALAI has written about Rituximab.
Connection Strength
0.158
-
The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab. Clin Lymphoma Myeloma Leuk. 2020 09; 20(9):e590-e596.
Score: 0.158